Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.

http://www.wikidata.org/entity/Q39739609

about

Role of DNA methylation in renal cell carcinoma Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility Renal cancer biomarkers: the promise of personalized care Alterations of the WNT7A gene in clear cell renal cell carcinomas A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain Epigenetics of kidney cancer and bladder cancer.Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line Prognostic significance of MST1R dysregulation in renal cell tumors Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.3-M syndrome: a growth disorder associated with IGF2 silencing.Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics The epigenetics of renal cell tumors: from biology to biomarkers.

P2860

Q26801268-E9A98EF9-1D16-4009-8764-8E6976C7DB80 Q28261753-FBD1AFD4-0460-4C2F-ADB6-1C6BB1CC1A43 Q30502257-058DD8E2-3D81-4423-8FD9-80382D8A02A7 Q32174136-1F875AF3-52DC-47EC-BFF3-F71FC798A97B Q33933511-6B151596-EC64-40A6-96D3-5C6360BBD01D Q33947935-08FFFD75-F3CF-46F6-9B67-E82B9CACE9D1 Q34144574-1B005D12-FAF3-4CF0-9080-F57A962C233C Q34422845-4E61973C-23DB-4164-8BCB-16DDD86C1B27 Q34442670-095650D4-3E48-477A-80AC-527D411FFB81 Q34454163-3BC717FB-B40B-4976-AB46-E44371024E2E Q34534982-326EB6B1-BD12-43A8-86C4-748467381559 Q34613635-9C519C25-7590-4A4F-958E-7476E6ED6653 Q34733206-6B431C5F-3D38-49D1-B4AF-951AEDA80C2C Q34998037-726FE1A0-92E2-4699-AF85-E3D56ECDC7DF Q35016547-9A842F57-9A27-4ECF-99D4-FB5907BF1D00 Q35032574-42B630D8-EC7C-4804-B34B-DD0FC5C58FDB Q35128280-C0890761-4F71-463C-8A6B-D7C793EB631E Q35582141-BFABC9A1-212D-4D37-9897-2C98F0640F1F Q35592187-25B0982F-0E7A-43C5-8EA8-826EEA2160FE Q35687321-48B65A1F-6A63-4D88-B211-0B834036DE42 Q35857807-ABF4C896-FA49-46DD-A85D-52089B7F9FF7 Q35911266-FBF5680D-DD16-4D7A-90D8-EF9B26F5A5AB Q36150977-F9F419CC-F3E5-4B2D-9DDC-A318A1DF3DCB Q36210416-D1D5FEFF-5F40-4D9C-85BB-2CD4DC22537E Q36489832-EB0A792F-B972-48C2-BD18-2D0C8B4877FD Q36557866-A22B2FFE-C8E3-466F-95FE-21ED991CD451 Q36567898-A2EC1F2B-C33A-421E-96F1-590DB74F6A62 Q36666935-A66F9E91-84DD-453F-A3E6-1A3BAB4C5AB6 Q37089951-26440E68-4ABD-4F1D-932E-97AF7C552AB1 Q37215552-B716F25B-37CC-4CD2-8406-CCD62BEA0047 Q37354559-38C2B119-A909-4663-AA12-4177BF8F258F Q37358224-D05DC54E-0CFB-4A9F-8617-46B34F1CAA68 Q37484160-855CCD29-853B-4DC2-9C45-AC4316D14166 Q37592077-AD8A44F7-CADC-4A87-B7D8-91F3BA4B5CB5 Q37607044-603703EC-DD86-4084-8737-BC58D202F8F1 Q37685151-A59324BA-0A22-4435-86AC-EF3BE3B0CD01 Q37703383-26016CBA-1B92-4D5E-B0F5-8183196C93F4 Q37706886-0AE29695-E48B-4040-B991-BAE54F59E704 Q37785109-15F5BA7F-94AD-467B-A8C1-CD456C7EB91A Q38016153-01D3D096-C907-451D-84D7-39F62AA1685A

P2860

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.

http://www.wikidata.org/entity/Q39739609

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Identification of candidate tu ...... lated in renal cell carcinoma.

@en

Identification of candidate tu ...... lated in renal cell carcinoma.

@nl

type

label

Identification of candidate tu ...... lated in renal cell carcinoma.

@en

Identification of candidate tu ...... lated in renal cell carcinoma.

@nl

prefLabel

Identification of candidate tu ...... lated in renal cell carcinoma.

@en

Identification of candidate tu ...... lated in renal cell carcinoma.

@nl

P1433

Q39739609-205CEBB2-ED46-431A-A693-25B3B78BE777

P1476

Q39739609-957FEB39-6166-4889-8274-BE68D4907B51

P2093

Q39739609-2D9C9390-495F-4AFF-AA68-1EDBC36BA744

Q39739609-6D50406A-2AEA-480E-BD29-007CD79D43CB

Q39739609-A62F3F35-94EB-4456-B6FF-156691B86594

Q39739609-B7CD7998-21E9-4403-8803-DC08E57FFBC9

Q39739609-B93B3945-D322-40F3-A1DD-7D8D30BB1046

Q39739609-E7B5E67E-152D-41EA-87B5-F00431AB7C4B

Q39739609-E8926F0E-4E03-43C5-9841-90CD462645FA

Q39739609-FD3FF66F-5872-423E-AA99-374F0500ABA3

P2860

Q39739609-007B70D3-A381-4CE4-850A-D6D61A1ABD09

Q39739609-124A4909-BFBD-4F39-B9F4-1E3DBEBFB42D

Q39739609-14A2A988-F486-4D43-AC9A-5DC43C85F26E

Q39739609-14BCA02B-CDB4-40C8-833B-AA2E51E06FFC

Q39739609-14C2A944-86BA-4EA7-8C57-55D5DD233AE2

Q39739609-1BD88EA7-3717-4BE5-AF7F-D2809C863368

Q39739609-21075948-E3BD-41D0-B5D2-D97380DD6CD3

Q39739609-274BF46B-AACF-4E0F-BFE3-AD5172962D52

Q39739609-274EAEAB-D09D-4745-B339-1BCE5572FF56

Q39739609-28BA0FA6-0946-4A7E-92D4-71C10EB90BD2

P2888

Q39739609-0DBF7200-3A08-4E05-96CE-84DE9D207A42

P304

Q39739609-0137F816-4507-409E-B652-B61D026156A3

P31

Q39739609-6D289ED3-3452-4DB3-A0B9-EE4E6D72E843

P356

Q39739609-CE72E3D6-FCD3-45CC-8F6A-A952519E1D50

P407

Q39739609-A45C7773-FCAF-4AEE-8123-25E98C5601C1

P433

Q39739609-E036AFDF-FF81-4BD8-847B-371A3E4D7EF9

P478

Q39739609-E345627A-2E36-4847-A8AC-7FA7C4F30028

P50

Q39739609-2CF88BA2-B5C9-4477-9CE1-EFEDED39F521

Q39739609-54D0032A-F9BB-4118-97DD-827421CE752D

P577

Q39739609-FD46E89A-00BA-496D-844F-4104EA858066

P5875

Q39739609-D210634B-04E2-424B-BB23-660EC7DEFE9F

P6179

Q39739609-ADEE1E99-95D0-4284-A16C-028AE5A03FF8

P698

Q39739609-4C106512-AAE6-4308-BD7B-1041C9CF5632

P932

Q39739609-87DD448D-94C2-414A-BEE6-A6025938971D

P356

P1433

P1476

Identification of candidate tu ...... lated in renal cell carcinoma.

@en

P2093

C Ricketts

http://www.w3.org/2001/XMLSchema#string

D Gentle

http://www.w3.org/2001/XMLSchema#string

E R Maher

http://www.w3.org/2001/XMLSchema#string

F Latif

http://www.w3.org/2001/XMLSchema#string

M Abdulrahman

http://www.w3.org/2001/XMLSchema#string

M R Morris

http://www.w3.org/2001/XMLSchema#string

M Yao

http://www.w3.org/2001/XMLSchema#string

T Kishida

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Undulin, an extracellular matrix glycoprotein associated with collagen fibrils

Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL

DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers

Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers

Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

Localization of a binding site for the proteoglycan decorin on collagen XIV (undulin)

P2888

P304

2104-2117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2009.493

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41429122

http://www.w3.org/2001/XMLSchema#string

P6179

1012933267

http://www.w3.org/2001/XMLSchema#string

P698

20154727

http://www.w3.org/2001/XMLSchema#string

P932

3021900

http://www.w3.org/2001/XMLSchema#string